Curetis N.V. (the “Company” and, together with its subsidiaries, “Curetis”), a developer of next-level molecular diagnostic solutions, today announced that the Company will be attending several key conferences in the third quarter of 2019.
European Biotech Investor Day 2019 by Goodwin, Solebury Trout, August 1, 2019 – New York, NY, USA – Company presentation and 1-on-1 investor meetings.
71st AACC Annual Scientific Meeting & Clinical Lab Expo, August 4-8, 2019 – Anaheim, CA, USA – Visit Curetis at booth #3611.
Southwestern Association for Clinical Microbiology (SWACM), September 4-7 – Oklahoma City, OK, USA – Meet Curetis’ U.S. sales team to learn more about the Unyvero LRT panel providing clear directions for the treatment of hospitalized pneumonia patients.
H.C. Wainwright Global Life Sciences Conference, September 8-9, 2019 – Lotte New York Palace Hotel, New York, NY, USA – Company presentation and 1-on-1 investor meetings.
Baader Investment Conference – Baader Small-Cap Day, September 27, 2019 – Hotel Sofitel Munich Bayerpost, Munich, Germany – Company presentation and 1-on-1 investor meetings.